Current Major Consultations http://www.pmprb-cepmb.gc.ca/view.asp?ccid=1207 en-ca PMPRB Guidelines Scoping Paper – High Level Overview of Potential New Framework (Canada Gazette, Part I) The Patented Medicine Prices Review Board (PMPRB) today published a scoping paper which provides its initial thoughts on how best to operationalize the Minister of Health’s proposed amendments to the Patented Medicines Regulations, which were published in the Canada Gazette, Part I on December 2, 2017. http://www.pmprb-cepmb.gc.ca/view.asp?ccid=1341&lang=en Mon, 12 Dec 2017 00:00:00 GMT http://www.pmprb-cepmb.gc.ca/view.asp?ccid=1241&lang=en PMPRB PMPRB.Information-Renseignements.CEPMB@pmprb-cepmb.gc.ca PMPRB Guidelines Modernization: Rethinking the Guidelines Phase 1 of this consultation concluded on October 31, 2016. Visit the Rethinking the Guidelines section to view the submissions we received. http://www.pmprb-cepmb.gc.ca/view.asp?ccid=1261&lang=en Tues, 29 Nov 2016 00:00:00 GMT http://www.pmprb-cepmb.gc.ca/view.asp?ccid=1261&lang=en PMPRB PMPRB.Information-Renseignements.CEPMB@pmprb-cepmb.gc.ca Public Comment Period Extended - PMPRB Guidelines Modernization Discussion Paper June 2016 The deadline to submit written comments for the Guidelines Modernization Discussion Paper has been extended to October 31, 2016. Through the Guidelines Modernization Discussion Paper, the PMPRB is seeking to generate an open, informed dialogue with stakeholders and members of the public on areas of the PMPRB’s drug pricing guidelines in need of reform as a result of changes to the pharmaceutical environment in Canada and abroad. http://www.pmprb-cepmb.gc.ca/view.asp?ccid=1260&lang=en Thurs, 20 Oct 2016 00:00:00 GMT http://www.pmprb-cepmb.gc.ca/view.asp?ccid=1260&lang=en PMPRB PMPRB.Information-Renseignements.CEPMB@pmprb-cepmb.gc.ca PMPRB Guidelines Modernization Discussion Paper June 2016 Through the Guidelines Modernization Discussion Paper, the PMPRB is seeking to generate an open, informed dialogue with stakeholders and members of the public on areas of the PMPRB’s drug pricing guidelines in need of reform as a result of changes to the pharmaceutical environment in Canada and abroad. http://www.pmprb-cepmb.gc.ca/view.asp?ccid=1260&lang=en Thurs, 23 Jun 2016 00:00:00 GMT http://www.pmprb-cepmb.gc.ca/view.asp?ccid=1260&lang=en PMPRB PMPRB.Information-Renseignements.CEPMB@pmprb-cepmb.gc.ca